Adage Capital Partners
TTPH

Adage Capital Partners’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Adage Capital Partners’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15,000
Closed -$14.2M – 773
2015
Q2 		$14.2M Sell
15,000
-5,000
-25% -$4.09M 0.04% 485
2015
Q1 		$14.7M Hold
20,000
– – 0.04% 478
2014
Q4 		$15.9M Sell
20,000
-5,227
-21% -$2.81M 0.04% 451
2014
Q3 		$10.1M Buy
+25,227
New +$6.76M 0.02% 533

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Adage Capital Partners's TTPH Position: Q3 2015 in Review

Adage Capital Partners sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2015, closing a stake of 15,000 shares — an estimated $14.2M sold.

Adage Capital Partners first reported a position in TTPH in Q3 2014 and held it in 4 quarters. The position peaked at $15.9M in Q4 2014. 105 funds tracked by Wall St. Rank hold TTPH as of Q3 2015.

  • Adage Capital Partners reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Adage Capital Partners sold 15,000 Tetraphase Pharmaceuticals, Inc. shares in Q3 2015, an estimated $14.2M.
  • Adage Capital Partners first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2014 and held it in 4 quarters.
  • Adage Capital Partners's Tetraphase Pharmaceuticals, Inc. position peaked at $15.9M in Q4 2014.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2015.

Based on Adage Capital Partners's 13F filing for Q3 2015, filed 16 Nov 2015.